help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Draper, L. B.
Right arrow Articles by Woodruff, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Draper, L. B.
Right arrow Articles by Woodruff, T. K.
Endocrinology Vol. 138, No. 7 3042-3046
Copyright © 1997 by The Endocrine Society


ARTICLES

The Uterine Myometrium Is a Target for Increased Levels of Activin A during Pregnancy

Lawrence B. Draper, Huira Chong, Eileen Wang and Teresa K. Woodruff

Departments of Medicine and Neurobiology and Physiology and The Center for Reproductive Sciences, Northwestern University, Chicago, Illinois 60611

Address all correspondence and requests for reprints to: Teresa K. Woodruff, Tarry Building 15–716, 303 Chicago Avenue, Chicago, Illinois 60611.

Activin A is a dimeric protein hormone that regulates numerous cellular functions. A clear physiological role for this molecule in pregnancy is suggested by previous studies in the human, wherein activin A rises dramatically as women approach parturition. To determine whether the rodent is a suitable animal model for further studies of activin action during pregnancy, the serum concentration of activin A was measured in pregnant rats. Activin A was detected in the serum of pregnant rats, beginning on day 12, and the serum concentration rose progressively through gestation (22-fold) and dramatically (140-fold) in labor. The potential target tissues for circulating activin were then identified in two ways. First, iodinated activin was injected into pregnant rats, and the tissues targeted by labeled ligand were identified in vivo. A tissue targeted by activin A in the pregnant rat was the uterine myometrium. To determine the ligand specificity of the uterine myometrial cells, the uteri of pregnant rats were collected and analyzed by in situ ligand binding. 125I-activin A binding was specific for the uterus myometrium, and the ligand binding was competed by unlabeled activin A but not by inhibin A. This result suggests that the receptor in this tissue compartment is an activin-specific receptor. The production of abundant activin A and the ability of exogenous ligand to target the myometrium of the uterus provides a pathway by which activin could regulate uterine function during pregnancy.




This article has been cited by other articles:


Home page
EndocrinologyHome page
P. Ciarmela, E. Wiater, and W. Vale
Activin-A in Myometrium: Characterization of the Actions on Myometrial Cells
Endocrinology, May 1, 2008; 149(5): 2506 - 2516.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
K Rae, K Hollebone, V Chetty, D Clausen, and J McFarlane
Follistatin serum concentrations during full-term labour in women significant differences between spontaneous and induced labour
Reproduction, November 1, 2007; 134(5): 705 - 711.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Debieve, L. Hinck, J.-M. Biard, P. Bernard, and C. Hubinont
Activin receptor expression and induction of apoptosis in rat blastocysts in vitro
Hum. Reprod., March 1, 2006; 21(3): 618 - 623.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
E J Gold, X Zhang, A M Wheatley, S L Mellor, M Cranfield, G P Risbridger, N P Groome, and J S Fleming
{beta}A- and {beta}C-activin, follistatin, activin receptor mRNA and {beta}C-activin peptide expression during rat liver regeneration
J. Mol. Endocrinol., April 1, 2005; 34(2): 505 - 515.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. A. Keelan, R. L. Zhou, L. W. Evans, N. P. Groome, and M. D. Mitchell
Regulation of Activin A, Inhibin A, and Follistatin Production in Human Amnion and Choriodecidual Explants by Inflammatory Mediators
Reproductive Sciences, September 1, 2000; 7(5): 291 - 296.
[Abstract] [PDF]


Home page
Hum ReprodHome page
A.E. O'Connor, J.R. McFarlane, S. Hayward, T. Yohkaichiya, N.P. Groome, and D.M. de Kretser
Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study
Hum. Reprod., March 1, 1999; 14(3): 827 - 832.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
E. Y. Wang, L. B. Draper, E. Lee, A. Polak, P. Sluss, J. Weiss, and T. K. Woodruff
Identification of Naturally Occurring Follistatin Complexes in Human Biological Fluids
Biol Reprod, January 1, 1999; 60(1): 8 - 13.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society